EndoTODAY | EndoATLAS | OPD

Parasite | Eso | Sto | Cancer | ESD

Boxim | DEX | Sono | Schedule

Home | Recent | Blog | Links

YouTube ¹Ù¸¥³»½Ã°æ¿¬±¸¼Ò


[¾Öµ¶ÀÚ Áõ·Ê ÆíÁö 9 (¸ð º´¿ø fellow)]

Previous | Next

[2015-11-7. ¾Öµ¶ÀÚ ÆíÁö]


Áõ·Ê 1

°£¾Ï(hepatocellular carcinoma)À¸·Î TACEÈÄ ¹ß»ýÇÑ liver abscess, hepatoduodenal fistula·Î ÃßÀû°üÂû ÁßÀÎ ºÐÀÔ´Ï´Ù.

ÃßÀû ³»½Ã°æ¿¡¼­ ½ÊÀÌÁöÀå ±¸ºÎ¿¡ hyperemic mass (ÀÏ°ß clot ó·³ º¸ÀÓ)°¡ ÀÖ¾î Á¶Á÷°Ë»ç¸¦ ÇÏ¿´°í metastatic HCC°¡ ³ª¿Ô½À´Ï´Ù. Fistula opening¿¡ HCC°¡ º¸¿©¼­ fistula tractÀ» µû¶ó¼­ HCC seeding µÈ °ÍÀ¸·Î ÃßÁ¤ÇÏ¿´½À´Ï´Ù. ½Å±âÇÑ case·Î º¸³»µå¸³´Ï´Ù.


[2015-11-9. ÀÌÁØÇà ´äÀå]

Èï¹Ì·Î¿î Áõ·ÊÀÔ´Ï´Ù. ±×·±µ¥ fistula tractÀ» Ÿ°í ÀüÀ̵Ǿú´ÂÁö ¾Æ´Ï¸é direct invasionÀÎÁö Á¶±Ý È®½ÇÇÏÁö ¾Ê´Ù°í »ý°¢µË´Ï´Ù. ¿Ö³Ä¸é CT¿¡¼­ viable tumor°¡ °¡±î¿î °÷¿¡ ÀÖÀ¸´Ï±î.... ¿©ÇÏÆ° ÁÁÀº Áõ·Ê ¼Ò°³ÇØ Áּż­ °í¸¿½À´Ï´Ù. °£¾ÏÀÇ À§Àå°ü ¼Ò°ß¿¡ ´ëÇÑ Áõ·Ê ¸î °³¸¦ ¼Ò°³ÇÕ´Ï´Ù.

1. Extrahepatic metastasis in HCC (30-75%)
- Lung, lymph nodes, bones, heart
- 3 routes: direct invasion, hematogenous metastasis, lympogenous meta

2. Gastrointestinal involvement (4-12%)
- M/C site: duodenum, stomach, colon, jejunum
- Contiguous GI tract via adhesion to the serosal side by a bulky tumor mass
- Associated with an extremly poor prognosis
- M/C symptom: bulky tumor burden & persistant occult or flank GI tract bleeding


Áõ·Ê 2

ÀüÁ¤ºÎ ÁøÇ༺ À§¾Ï(signet ring cell carcinoma T4 N1)À¸·Î subtotal gastrectomy with STG B-II ¼ö¼ú ¹× adjuvant chemotherapy ½ÃÇà¹Þ°í ÃßÀû°üÂû Áß À§³»½Ã°æ¿¡¼­ remnant stomachÀÇ AGC B-IV ¼Ò°ßÀÌ º¸¿´½À´Ï´Ù. Á¶Á÷°Ë»ç¸¦ ÇÏ¿´°í signet ring cell carcinoma°¡ ³ª¿Ô½À´Ï´Ù.


[2015-11-9. ÀÌÁØÇà ´äÀå]

Proximal resection marginÀÌ ÃæºÐÇÔ¿¡µµ ºÒ±¸ÇÏ°í remnant stomach¿¡ º¸¸¸ 4Çü ÁøÇ༺À§¾ÏÀÌ ¹ß»ýÇÑ Æ¯ÀÌÇÑ °æ¿ì¿´´ø °Í °°½À´Ï´Ù.

ÀÜÀ§¾Ï (remnant gastric cancer) Áß °¡Àå Áø´Üµµ ¾î·Æ°í ¿¹Èĵµ ³ª»Û °ÍÀº ÀÜÀ§¿¡¼­ ¹ß»ýÇÑ º¸¸¸ 4Çü ÁøÇ༺À§¾ÏÀÔ´Ï´Ù. Áõ·Ê Çϳª ¼Ò°³ÇÕ´Ï´Ù. À§¾ÆÀüÀýÁ¦¼ú 5³â ÈÄ ÀÜÀ§ÀÇ º¸¸¸ 4Çü ÁøÇ༺À§¾ÏÀ¸·Î Áø´ÜµÈ ȯÀÚÀÔ´Ï´Ù. ´ëÀå ħ¹üµµ ÀÖ¾ú½À´Ï´Ù. ¸Å¿ì µå¹® Áõ·ÊÀÔ´Ï´Ù. ¹«Ã´ Áø´ÜÇϱ⠾î·Æ½À´Ï´Ù. Æò»ó½Ã¿¡µµ ÀÜÀ§ÀÇ Á¡¸·Àº ¾à°£ ºÎ¾îº¸À̱⠶§¹®¿¡ º¸¸¸ 4Çü ÁøÇ༺ À§¾Ï°ú ±¸ºÐÇϱ⠾î·Æ½À´Ï´Ù.

@ Âü°í: EndoTODAY ÀÜÀ§¾Ï


Áõ·Ê 3

±Ë¾ç¼º ´ëÀå¿° °üÇØ»óÅÂÀε¥ annual surveillance ³»½Ã°æ Áß ¿ëÁ¾ÀÌ ¹ß°ßÇÏ¿© ¿ëÁ¾ÀýÁ¦¼úÀ» ½ÃÇàÇÏ¿´°í retention polypÀ¸·Î ³ª¿Ô½À´Ï´Ù. Á¦°¡ ¹®Çå °Ë»öÇغ» ¹Ù·Î´Â juvenile polypÀ¸·Î ºÐ·ùµÇ¾î ÈÄõÀûÀ¸·Î ¹ß»ýÇÏ´Â °æ¿ì´Â µå¹°´Ù°í µÇÀÖ´øµ¥¿ä...


[References]

1) EndoTODAY ¾Öµ¶ÀÚ Áõ·Ê ÆíÁö

2) Hamartomatous polyposis syndrome (PDF)

© ÀÏ¿ø³»½Ã°æ±³½Ç ¹Ù¸¥³»½Ã°æ¿¬±¸¼Ò ÀÌÁØÇà. EndoTODAY Endoscopy Learning Center. Lee Jun Haeng.